<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Abderrahmani Wissal — HTBAA Fall 2026 :: 2026a-wissal-abderrahmani</title><link>https://pages.htgaa.org/2026b/wissal-abderrahmani/index.html</link><description>About me Hi, I’m Wissal, a molecular biology engineer fascinated by synthetic biology, mammalian cell engineering, and anything related to using biology to solve real-world problems 💫&#10;I love learning new things, meeting new people, and discovering new cultures. I enjoy discussions about philosophy, history, and psychology. I believe interdisciplinarity holds great potential for addressing some of the most challenging issues of our century, and I particularly value HTB(G)AA’s constructionist approach to learning and its vision of radical inclusion.</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026b/wissal-abderrahmani/index.xml" rel="self" type="application/rss+xml"/><item><title>Week 1 HW: Final Project Ideas</title><link>https://pages.htgaa.org/2026b/wissal-abderrahmani/week-01-hw-project-ideas/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/wissal-abderrahmani/week-01-hw-project-ideas/index.html</guid><description>Killer T cells surrounding a cancer cell.&#10;Image source: Harvard Medical School&#10;A Programmable SynNotch CAR-T Platform for Neuroblastoma 1.🪄 What I would like to biomanufacture, and Why ? Neuroblastoma is a cancer of the developing nervous system that primarily affects children. Although treatment outcomes have improved, patients with high-risk, relapsed, or refractory disease continue to have limited effective therapeutic options.</description></item><item><title>Week 2 HW: DNA Design</title><link>https://pages.htgaa.org/2026b/wissal-abderrahmani/week-02-hw-dna-design/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/wissal-abderrahmani/week-02-hw-dna-design/index.html</guid><description>Building the GD2-SynNotch–GPC2 CAR-T Genetic Circuit This week, I translated the therapeutic concept proposed in Homework 1 into defined genetic parts and three buildable lentiviral constructs.&#10;GD2 sensing → SynNotch activation → GPC2-CAR + EGFP expression → GPC2 recognition → T-cell activation + mbIL-15 support 1. 🧬 Define the expression target 1.a What molecules am I expressing? For my project, I will express two synthetic receptors (GD2-SynNotch and GPC2-CAR), one membrane-tethered cytokine (IL-15), and a fluorescent reporter (EGFP).</description></item><item><title>Final Project</title><link>https://pages.htgaa.org/2026b/wissal-abderrahmani/final-project/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/wissal-abderrahmani/final-project/index.html</guid><description/></item></channel></rss>